In May, Novo Nordisk agreed a partnership deal with Septerna to jointly discover and develop multiple oral small molecule obesity and cardiometabolic disease drugs
2018 Apr;57(3):965-979
This data is invaluable for troubleshooting and for conversations with your provider about dose adjustments
Future research should prioritize elucidating the molecular mechanisms behind the antitumor effects, refining individualized treatment strategies, investigating early tumor prevention applications, assessing potential benefits for non-diabetic populations, advancing the development of novel therapies, establishing robust safety monitoring frameworks, and building precision medicine decision-making platforms
Ro Ro is a strong telehealth platform that offers personalized medical care across different medical conditions, such as weight loss, fertility, and sexual health
Practice Pearl(s) The dosing regimen of glucagon-like peptide-1 (GLP-1) agonists is characterized by careful initiation and titration to ensure optimal glycemic control while minimizing potential adverse effects
